<SEC-DOCUMENT>0001104659-17-062168-index.html : 20171013 <SEC-HEADER>0001104659-17-062168.hdr.sgml : 20171013 <ACCEPTANCE-DATETIME>20171013171658 ACCESSION NUMBER: 0001104659-17-062168 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20171013 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20171013 DATE AS OF CHANGE: 20171013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 171137139 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a17-23934_38k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a17-23934_38k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>a17-23934_3ex1d1.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: a17-23934_3ex1d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a17-23934_3ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a17-23934_3ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g239343kii001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g239343kii001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g239343kii002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g239343kii002.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g239343kii003.gif <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g239343kii003.gif
</DOCUMENT> </SEC-DOCUMENT>